Dermata Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Dermata Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q2 2022.
  • Dermata Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2022 was $0.000, a 100% decline year-over-year.
  • Dermata Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2022 was $655.000.
  • Dermata Therapeutics, Inc. annual Interest Expense for 2021 was $45.6K, a 76.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $655 $0 -$1.82K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.48K $0 -$43.1K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $45.6K $4.00 Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $651 -$56.7K -98.9% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.82K -$27K -93.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $43.1K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $57.3K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $28.9K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.